The 3rd MediInnovate Conference: Breakthroughs in Medicine and Health Sciences (MHS26)
Locations
- Singapore (Offline): National University of Singapore
- Online: Link to be provided by the organizer
Date & Details
- Date: March 27, 2026
- Mode: Hybrid (Singapore | Online)
Introduction
Building on the transformative success of our previous gathering, the American Life and Science Association (ALSA) is proud to announce the Biological Sciences and Biotechnology Conference 2026. Set against the vibrant backdrop on March 27, 2026, this third edition continues its mission as a premier global stage for the convergence of life sciences and technological ingenuity.
As we enter a new chapter of biological discovery, MHS26 remains dedicated to bridging the gap between foundational research and real-world application. This year’s forum will dive deeper into the next generation of synthetic biology, advanced gene editing, and biomanufacturing, while placing a renewed emphasis on the scalability of regenerative medicine and the complexities of global bioethics.
What to Expect in 2026:
- Interdisciplinary Synergy: A unique gathering of researchers, industry titans, and policy-makers designed to spark cross-sector partnerships.
- Advanced Technical Tracks: Exploring the frontiers of CRISPR-based therapies, environmental biotechnology, and bio-based production ecosystems.
- Translational Focus: Expert-led panels and workshops dedicated to the "bench-to-bedside" journey, ensuring scientific breakthroughs lead to sustainable healthcare solutions.
- Future-Ready Dialogue: Addressing the regulatory frameworks and technological shifts required to navigate the rapidly evolving bioscience landscape.
Whether you are unveiling cutting-edge research or seeking the next breakthrough in bio innovation, the 2026 Biological Sciences and Biotechnology Conference offers a critical platform for interdisciplinary collaboration. Join us as we continue to shape the trajectory of global health sciences and drive the future of the biotechnology revolution.
Conference Agenda
| Time | Session Title | Speaker/Moderator |
|---|---|---|
| 08:30 - 09:00 | Registration | — |
| 09:00 - 09:30 | Opening Remarks | ALSA Representatives & XJTU Faculty |
| 09:30 - 11:00 | Keynote I: Frontiers in Neurological Biomedicine | Dr. Rabab Ali Hussen Abumalloh (National University of Singapore) |
| 11:00 - 11:30 | Break | — |
| 11:30 - 13:00 | Keynote II: Epidemiology & Clinical Progress in Ophthalmology | Dr. Muhammad Numan (2nd Affiliated Hospital of XJTU) |
| 13:00 - 14:00 | Lunch | — |
| 14:00 - 15:00 | Q & A | — |
| 15:00 - 15:30 | Closing Remarks | Organizing Committee |
Keynote Speakers
Rabab Ali Hussen Abumalloh
Biomedicine
Associate Professor
National University of Singapore
Muhammad Numan
Public Health and Epidemiology
Doctor
Xi'an Jiaotong University
Editorial Team
Editor-in-chief
Raees Ahmad (Xi'an Jiaotong University)
Associate Editor
Zunaira Khalid (University of Lahore)
Editorial Board Member
Muhammad Numan (The Second Affiliated Hospital of Xi’an Jiaotong University), Yu Diao (Xi'an Jiaotong University)
All submissions will be screened and peer-reviewed by the reviewers with MDs, PHDs, Doctors of Engineering and associate professors from the universities and research institutes worldwide.
The peer-review process will be double-blind peer-review.
